CHARLOTTE, N.C., Jan. 9, 2025
/PRNewswire/ -- Dechert LLP announced today the addition of
Jennifer Csik Hutchens as a partner
in its corporate and securities practice, further bolstering the
firm's capabilities in healthcare and life sciences transactions
and regulatory work. Ms. Hutchens leads Dechert's healthcare
regulatory practice and is a leader in the firm's healthcare
industry practice and cross-practice group healthcare initiatives.
She is based in the firm's Charlotte office.
"Jennifer's deep expertise in healthcare transactions and
regulatory work, especially in advising private equity and
other strategic clients, aligns perfectly with our strategic goal
to deepen engagement with clients in the healthcare and life
sciences sectors," said Mark
Thierfelder, co-chair of Dechert.
"We are thrilled to welcome Jennifer to the firm. Her extensive
experience and robust industry network will be invaluable as we
continue to focus on expanding our healthcare and life sciences
capabilities," said Ken Young,
co-chair of Dechert's corporate and securities practice.
"Jennifer's client-centric approach and focus on cutting edge
topics in the industry make her a natural fit for Dechert. Her
skills will be particularly valuable to our private equity and
other clients in this sector as she helps them navigate complex
regulatory landscapes and implement innovative, first-of-their-kind
solutions and transactions."
Ms. Hutchens joins Dechert from an international law firm, where
she served as global head of healthcare and life sciences. She
began her legal career at a Charlotte-based firm, becoming a partner and
co-chair of its healthcare practice in 2015. Ms. Hutchens provides
broad transactional experience, offering commercially practical and
responsive counsel on joint ventures, mergers and acquisitions,
healthcare contracting, and other collaboration transactions. Her
regulatory practice focuses on navigating complex healthcare laws
and regulations and providing comprehensive compliance advice. She
advises strategic entities, including hospitals and healthcare
companies, institutional investors, private equity-backed
healthcare funds, portfolio companies, and roll-up networks.
"Dechert's strategic direction and leading platform provide the
perfect environment for me to elevate my practice and best serve my
clients," said Ms. Hutchens. "I am excited about the opportunities
to further develop an industry-leading healthcare practice at
Dechert and to contribute to the firm's continued growth in the
healthcare and life sciences space."
A summa cum laude graduate of both Duke
University and the Duke
University School of Law, Ms. Hutchens has been recognized
by the Best Lawyers of America in healthcare law since 2015 and
ranked Band 2 in healthcare by Chambers USA in North
Carolina since 2018. She also serves on the Board of
Directors of the American Health Law Association (AHLA), including
as a member of AHLA's finance committee.
Dechert has been at the forefront of advising private equity
firms for over 40 years and ranked among the top law firms for U.S.
and Global PE Buyouts and Global M&A by Bloomberg, Mergermarket
and Refinitiv. With more than 350 private equity and private
investment clients, we have unique insights into how the industry
has evolved and where it's going next. Our global team advises
private equity, private credit and other alternative asset managers
on flexible solutions at every phase of the investment life
cycle.
Dechert's life sciences group delivers industry expertise and
commercial judgment to help leading life sciences and healthcare
companies navigate their most complex and demanding transactional,
intellectual property and litigation matters. Our global
multi-disciplinary team has the reach, resources and experience to
provide comprehensive transactional, regulatory and dispute
resolution services anywhere in the world. Learn more.
About Dechert
Dechert is a global law firm that advises asset managers,
financial institutions and corporations on issues critical to
managing their business and their capital – from high-stakes
litigation to complex transactions and regulatory matters. We
answer questions that seem unsolvable, develop deal structures that
are new to the market and protect clients' rights in extreme
situations. Our nearly 1,000 lawyers across 19 offices globally
focus on the financial services, private equity, private credit,
real estate, life sciences and technology sectors.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dechert-bolsters-healthcare-and-life-sciences-expertise-with-addition-of-jennifer-csik-hutchens-302347434.html
SOURCE Dechert LLP
